Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
Palumbo, Antonio, Hajek, Roman, Delforge, Michel, Kropff, Martin, Petrucci, Maria Teresa, Catalano, John, Gisslinger, Heinz, Wiktor-Jędrzejczak, Wiesław, Zodelava, Mamia, Weisel, Katja, Cascavilla, Nicola, Iosava, Genadi, Cavo, Michele, Kloczko, Janusz, Bladé, Joan, Beksac, Meral, Spicka, Ivan, Plesner, Torben, Radke, Joergen, Langer, Christian, Yehuda, Dina Ben, Corso, Alessandro, Herbein, Lindsay, Yu, Zhinuan, Mei, Jay, Jacques, Christian, Dimopoulos, Meletios A
Published in The New England journal of medicine (10.05.2012)
Published in The New England journal of medicine (10.05.2012)
Get full text
Journal Article
Subcutaneous engineered factor VIIa marzeptacog alfa (activated) in hemophilia with inhibitors: Phase 2 trial of pharmacokinetics, pharmacodynamics, efficacy, and safety
Mahlangu, Johnny, Levy, Howard, Kosinova, Marina V., Khachatryan, Heghine, Korczowski, Bartosz, Makhaldiani, Levani, Iosava, Genadi, Lee, Martin, Del Greco, Frank
Published in Research and practice in thrombosis and haemostasis (01.08.2021)
Published in Research and practice in thrombosis and haemostasis (01.08.2021)
Get full text
Journal Article
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
Mateos, María-Victoria, Dimopoulos, Meletios A., Cavo, Michele, Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Kaplan, Polina, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna M., Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Chiu, Christopher, Wang, Jianping, Carson, Robin, Crist, Wendy, Deraedt, William, Nguyen, Huong, Qi, Ming, San-Miguel, Jesus
Published in The New England journal of medicine (08.02.2018)
Published in The New England journal of medicine (08.02.2018)
Get full text
Journal Article
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
Mateos, Maria-Victoria, Cavo, Michele, Blade, Joan, Dimopoulos, Meletios A, Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna Marina, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Krevvata, Maria, Chen, Ying, Wang, Jianping, Kudva, Anupa, Ukropec, Jon, Wroblewski, Susan, Qi, Ming, Kobos, Rachel, San-Miguel, Jesus
Published in The Lancet (British edition) (11.01.2020)
Published in The Lancet (British edition) (11.01.2020)
Get full text
Journal Article
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
Mateos, María-Victoria, Dimopoulos, Meletios A, Cavo, Michele, Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Kaplan, Polina, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna M, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Chiu, Christopher, Wang, Jianping, Carson, Robin, Crist, Wendy, Deraedt, William, Nguyen, Huong, Qi, Ming, San-Miguel, Jesus
Published in The New England journal of medicine (08.02.2018)
Published in The New England journal of medicine (08.02.2018)
Get full text
Journal Article
Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
PALUMBO, Antonio, HAJEK, Roman, CASCAVILLA, Nicola, LOSAVA, Genadi, CAVO, Michele, KLOCZKO, Janusz, BLADE, Joan, BEKSAC, Meral, SPICKA, Ivan, PLESNER, Torben, RADKE, Joergen, LANGER, Christian, DELFORGE, Michel, BEN YEHUDA, Dina, CORSO, Alessandro, HERBEIN, Lindsay, ZHINUAN YU, MEI, Jay, JACQUES, Christian, DIMOPOULOS, Meletios A, KROPFF, Martin, PETRUCCI, Maria Teresa, CATALANO, John, GISSLINGER, Heinz, WIKTOR-JEDRZEJCZAK, Wiesław, ZODELAVA, Mamia, WEISEL, Katja
Published in The New England journal of medicine (10.05.2012)
Published in The New England journal of medicine (10.05.2012)
Get full text
Journal Article
An Open Label, Phase 2 Study to Assess the Efficacy and Safety of Tenalisib (RP6530), a PI3K δ/γ and SIK3 Inhibitor, in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Grosicki, Sebastian, Iosava, Genadi, Zodelava, Mamia, Tzvetkov, Nikolay, Robak, Tadeusz, Radinoff, Atanas, Routhu, Kasi Viswanath, Barde, Prajak, Nair, Ajit Mohanchandran
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
Broome, Catherine M, McDonald, Vickie, Miyakawa, Yoshitaka, Carpenedo, Monica, Kuter, David J, Al-Samkari, Hanny, Bussel, James B, Godar, Marie, Ayguasanosa, Jaume, De Beuf, Kristof, Rodeghiero, Francesco, Michel, Marc, Newland, Adrian, Fillitz, Michael, Knoebl, Paul, Meers, Stef, Amine, Ismail Mohamad, Gumulec, Jaromir, Hlusi, Antonin, Mayer, Jiri, Quittet, Philippe, Viallard, Jean-Francois, Betaneli, Magdana, Datikashvili-David, Irine, Iosava, Genadi, Makhaldiani, Levan, Rejto, Laszlo, Sharashenidze, Nino, Groepper, Stefanie, Röth, Alexander, Hamed, Aryan, Illes, Arpad, Artoni, Andrea, Bocchia, Monica, Gamberi, Barbara, Borchiellini, Alessandra, Oliva, Esther Natalie, Patriarca, Andrea, Tomassetti, Simona, Ando, Kiyoshi, Handa, Hiroshi, Katsutani, Shinya, Nishiwaki, Kaichi, Ito, Shoko, Ito, Tomoki, de Boer, Fransien, Jansen, A.J. Gerard, Ciepluch, Hanna, Fornagiel, Szymon, Grosicki, Sebastian, Soroka-Wojtaszko, Maria, Trelinski, Jacek, Bakirov, Bulat, Borisenkova, Elena, Volodicheva, Elena, Shatokhin, Yuri, Proydakov, Andrey, Alonso, Maria Aranzazu, Mingot-Castellano, María Eva, Sanchez-Gonzalez, Blanca, Valcarcel Ferreiras, David, Ayli, Meltem, Hacibekiroglu, Tuba, Demir, Ahmet Muzaffer, Nalçaci, Meliha, Sonmez, Mehmet, Tombak, Anil, Toprak, Selami Kocak, Turgut, Burhan, Vural, Filiz, Yagci, Munci, Altuntas, Fevzi, Turgut, Mehmet, Kaya, Emin, Romanyuk, Nataliya, Kazmi, Syed Rashid Saeed, Broome, Catherine, Cataland, Spero, Doshi, Ketan, Lentz, Steven R., Boxer, Michael, Rosenberg, Richard
Published in The Lancet (British edition) (04.11.2023)
Published in The Lancet (British edition) (04.11.2023)
Get full text
Journal Article
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE
Mateos, Maria-Victoria, Dimopoulos, Meletios A., Cavo, Michele, Suzuki, Kenshi, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Pour, Ludek, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna Marina, Campbell, Philip, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Iida, Shinsuke, Bladé, Joan, Ukropec, Jon, Pei, Huiling, Van Rampelbergh, Rian, Kudva, Anupa, Qi, Ming, San-Miguel, Jesus
Published in Clinical lymphoma, myeloma and leukemia (01.11.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.11.2021)
Get full text
Journal Article
Phase 2/3 Trial of Subcutaneously Administered Marzeptacog Alfa (activated) an Engineered FVIIa in Hemophilia with Inhibitors - Pharmacokinetics, Pharmacodynamics, Safety and Efficacy
Levy, Howard, Makhaldiani, Levani, Iosava, Genadi, Mahlangu, Johnny, Kosinova, Marina V, Khacchatryan, Heghine, Del Greco, Frank, Booth, Frank V. McL
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Alcyone Study
Mateos, Maria-Victoria, San-Miguel, Jesús, Cavo, Michele, Bladé Creixenti, Joan, Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Pour, Ludek, Grosicki, Sebastian, Crepaldi, Andre H, Liberati, Anna Marina, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Pei, Huiling, Krevvata, Maria, Carson, Robin, Borgsten, Fredrik, Dimopoulos, Meletios A.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Overall Survival in Alcyone
Mateos, Maria-Victoria, Cavo, Michele, Bladé, Joan, Dimopoulos, Meletios A., Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre H, Liberati, Anna Marina, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Krevvata, Maria, Wang, Jianping, Kudva, Anupa, Ukropec, Jon, Wroblewski, Susan, Kobos, Rachel, San-Miguel, Jesús
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor
Khayat, Claudia Djambas, Iosava, Genadi, Romashevskaya, Irina, Stasyshyn, Oleksandra, Lopez, Marta Julia, Pompa, Maria Teresa, Rogosch, Tobias, Seifert, Wilfried
Published in Journal of blood medicine (31.07.2021)
Published in Journal of blood medicine (31.07.2021)
Get full text
Journal Article
Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients
Djambas Khayat, Claudia, Iosava, Genadi, Romashevskaya, Irina, Stasyshyn, Oleksandra, Lopez, Marta Julia, Pompa, Maria Teresa, Rogosch, Tobias, Seifert, Wilfried
Published in Journal of blood medicine (01.06.2021)
Published in Journal of blood medicine (01.06.2021)
Get full text
Journal Article
One-Year Update of a Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Patients (Pts) with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): Alcyone
Dimopoulos, Meletios A, Mateos, Maria-Victoria, Cavo, Michele, Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Kaplan, Polina, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre H, Liberati, Anna Marina, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Chiu, Christopher, Wang, Jianping, Kudva, Anupa, Kobos, Rachel, Wroblewski, Susan, Qi, Ming, San-Miguel, Jesus F, Bladé, Joan
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate
Auerswald, Guenter, Khayat, Claudia Djambas, Stasyshyn, Oleksandra, Iosava, Genadi, Romashevskaya, Irina, Lopez, Marta Julia, Seifert, Wilfried, Rogosch, Tobias
Published in Journal of blood medicine (30.06.2020)
Published in Journal of blood medicine (30.06.2020)
Get full text
Journal Article
Rviii-Singlechain Pharmacokinetics and Safety in Children Less Than 12 Years of Age
Djambas Khayat, Claudia, Stasyshyn, Oleksandra, Iosava, Genadi, Ong, Jeannie B, Abdul Karim, Faraizah, Bensen-Kennedy, Debra M., St. Ledger, Katie, Limsakun, Tharin, Veldman, Alex, Pabinger, Ingrid
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Ineligible for Transplant (ALCYONE)
Mateos, Maria-Victoria, Dimopoulos, Meletios A., Cavo, Michele, Suzuki, Kenshi, Jakubowiak, Andrzej J., Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Kaplan, Polina, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre H, Liberati, Anna Marina, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Chiu, Christopher, Wang, Jianping, Carson, Robin, Crist, Wendy, Deraedt, William, Nguyen, Marie, Qi, Ming, San-Miguel, Jesus F.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)
Auerswald, Guenter, Djambas Khayat, Claudia, Stasyshyn, Oleksandra, Iosava, Genadi, Romashevskaya, Irina, López, Marta Julia, Seifert, Wilfried, Rogosch, Tobias
Published in Journal of blood medicine (01.01.2020)
Published in Journal of blood medicine (01.01.2020)
Get full text
Journal Article
Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients <12 Years of Age with Hemophilia A (SWIFTLY-HA Study)
Djambas Khayat, Claudia, Iosava, Genadi, Romashevskaya, Irina, Stasyshyn, Oleksandra, Lopez, Marta Julia, Pompa, Maria Teresa, Rogosch, Tobias, Seifert, Wilfried
Published in Journal of blood medicine (01.01.2021)
Published in Journal of blood medicine (01.01.2021)
Get full text
Journal Article